Baudax Bioinc Stock Buy Hold or Sell Recommendation
| BXRX Stock | USD 0.01 0.0001 0.94% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Baudax BioInc is 'Strong Sell'. Macroaxis provides Baudax BioInc buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BXRX positions. The advice algorithm takes into account all of Baudax BioInc's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Baudax BioInc's buy or sell advice are summarized below:
Real Value 6.01 | Target Price 24 | Hype Value 0.01 | Market Value 0.0105 | Naive Value 0.009151 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Baudax BioInc given historical horizon and risk tolerance towards Baudax BioInc. When Macroaxis issues a 'buy' or 'sell' recommendation for Baudax BioInc, the advice is generated through an automated system that utilizes algorithms and statistical models.
Baudax |
Execute Baudax BioInc Buy or Sell Advice
The Baudax recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Baudax BioInc. Macroaxis does not own or have any residual interests in Baudax BioInc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Baudax BioInc's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Baudax BioInc Trading Alerts and Improvement Suggestions
| Baudax BioInc generated a negative expected return over the last 90 days | |
| Baudax BioInc has high historical volatility and very poor performance | |
| Baudax BioInc has some characteristics of a very speculative penny stock | |
| Baudax BioInc has a very high chance of going through financial distress in the upcoming years | |
| The company currently holds 7.12 M in liabilities with Debt to Equity (D/E) ratio of 2.26, implying the company greatly relies on financing operations through barrowing. Baudax BioInc has a current ratio of 0.52, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Baudax BioInc until it has trouble settling it off, either with new capital or with free cash flow. So, Baudax BioInc's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Baudax BioInc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Baudax to invest in growth at high rates of return. When we think about Baudax BioInc's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 1.27 M. Net Loss for the year was (7.15 M) with loss before overhead, payroll, taxes, and interest of (5.74 M). | |
| Baudax BioInc currently holds about 5.65 M in cash with (14.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Baudax BioInc has a poor financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Disposition of tradable shares by Kim Yong Chan of Baudax BioInc subject to Rule 16b-3 |
Baudax BioInc Returns Distribution Density
The distribution of Baudax BioInc's historical returns is an attempt to chart the uncertainty of Baudax BioInc's future price movements. The chart of the probability distribution of Baudax BioInc daily returns describes the distribution of returns around its average expected value. We use Baudax BioInc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Baudax BioInc returns is essential to provide solid investment advice for Baudax BioInc.
| Mean Return | -0.51 | Value At Risk | -18.75 | Potential Upside | 15.48 | Standard Deviation | 12.38 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Baudax BioInc historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Baudax Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Baudax BioInc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Baudax BioInc backward and forwards among themselves. Baudax BioInc's institutional investor refers to the entity that pools money to purchase Baudax BioInc's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Virtu Financial Llc | 2023-12-31 | 0.0 | Sittner & Nelson, Llc | 2023-09-30 | 0.0 | Blackrock Inc | 2023-12-31 | 0.0 | Advisor Group Holdings, Inc. | 2023-12-31 | 0.0 | Xtx Topco Ltd | 2023-12-31 | 0.0 | Creative Planning Inc | 2023-09-30 | 0.0 | State Street Corporation | 2023-12-31 | 0.0 | Susquehanna International Group, Llp | 2023-12-31 | 0.0 | Wells Fargo & Co | 2023-12-31 | 0.0 | Jane Street Group, Llc | 2023-09-30 | 0.0 | Tower Research Capital Llc | 2023-12-31 | 0.0 |
Baudax BioInc Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Baudax BioInc or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Baudax BioInc's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Baudax stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.76 | |
β | Beta against NYSE Composite | 2.78 | |
σ | Overall volatility | 12.65 | |
Ir | Information ratio | -0.05 |
Baudax BioInc Volatility Alert
Baudax BioInc is displaying above-average volatility over the selected time horizon. Baudax BioInc is a penny stock. Although Baudax BioInc may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Baudax BioInc. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Baudax instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Baudax BioInc Fundamentals Vs Peers
Comparing Baudax BioInc's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Baudax BioInc's direct or indirect competition across all of the common fundamentals between Baudax BioInc and the related equities. This way, we can detect undervalued stocks with similar characteristics as Baudax BioInc or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Baudax BioInc's fundamental indicators could also be used in its relative valuation, which is a method of valuing Baudax BioInc by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Baudax BioInc to competition |
| Fundamentals | Baudax BioInc | Peer Average |
| Return On Equity | -47.04 | -0.31 |
| Return On Asset | -1.15 | -0.14 |
| Operating Margin | (27.60) % | (5.51) % |
| Current Valuation | 17.72 M | 16.62 B |
| Shares Outstanding | 43.59 M | 571.82 M |
| Shares Owned By Insiders | 0.01 % | 10.09 % |
| Shares Owned By Institutions | 2.68 % | 39.21 % |
| Number Of Shares Shorted | 493.56 K | 4.71 M |
| Price To Earning | 0.03 X | 28.72 X |
| Price To Book | 0.68 X | 9.51 X |
| Price To Sales | 0.75 X | 11.42 X |
| Revenue | 1.27 M | 9.43 B |
| Gross Profit | (5.74 M) | 27.38 B |
| EBITDA | (34.76 M) | 3.9 B |
| Net Income | (7.15 M) | 570.98 M |
| Cash And Equivalents | 5.65 M | 2.7 B |
| Cash Per Share | 0.28 X | 5.01 X |
| Total Debt | 7.12 M | 5.32 B |
| Debt To Equity | 2.26 % | 48.70 % |
| Current Ratio | 0.53 X | 2.16 X |
| Book Value Per Share | (0.84) X | 1.93 K |
| Cash Flow From Operations | (14.31 M) | 971.22 M |
| Short Ratio | 0.19 X | 4.00 X |
| Earnings Per Share | (94.13) X | 3.12 X |
| Target Price | 24.0 | |
| Number Of Employees | 9 | 18.84 K |
| Beta | 1.58 | -0.15 |
| Market Capitalization | 950.33 K | 19.03 B |
| Total Asset | 10.03 M | 29.47 B |
| Retained Earnings | (190.9 M) | 9.33 B |
| Working Capital | (15.11 M) | 1.48 B |
| Current Asset | 21.72 M | 9.34 B |
| Current Liabilities | 7.92 M | 7.9 B |
Note: Disposition of tradable shares by Kim Yong Chan of Baudax BioInc subject to Rule 16b-3 [view details]
Baudax BioInc Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Baudax . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.0804 | |||
| Daily Balance Of Power | (0.11) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 0.0107 | |||
| Day Typical Price | 0.0107 | |||
| Market Facilitation Index | 9.0E-4 | |||
| Price Action Indicator | (0.0003) | |||
| Period Momentum Indicator | (0.0001) | |||
| Relative Strength Index | 71.43 |
About Baudax BioInc Buy or Sell Advice
When is the right time to buy or sell Baudax BioInc? Buying financial instruments such as Baudax Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 12.0M | 11.9M | 10.7M | 13.6M | Total Assets | 53.3M | 10.0M | 9.0M | 8.6M |
Use Investing Ideas to Build Portfolios
In addition to having Baudax BioInc in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large Growth Funds Thematic Idea Now
Large Growth Funds
Funds or Etfs that invest in stocks of large-sized companies with above-average risk and growth rate. The Large Growth Funds theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Growth Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Baudax BioInc Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Baudax Stock please use our How to Invest in Baudax BioInc guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Baudax Stock analysis
When running Baudax BioInc's price analysis, check to measure Baudax BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baudax BioInc is operating at the current time. Most of Baudax BioInc's value examination focuses on studying past and present price action to predict the probability of Baudax BioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baudax BioInc's price. Additionally, you may evaluate how the addition of Baudax BioInc to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is Baudax BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baudax BioInc. If investors know Baudax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baudax BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (94.13) | Revenue Per Share 0.318 | Quarterly Revenue Growth (0.23) | Return On Assets (1.15) | Return On Equity (47.04) |
The market value of Baudax BioInc is measured differently than its book value, which is the value of Baudax that is recorded on the company's balance sheet. Investors also form their own opinion of Baudax BioInc's value that differs from its market value or its book value, called intrinsic value, which is Baudax BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baudax BioInc's market value can be influenced by many factors that don't directly affect Baudax BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Baudax BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baudax BioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baudax BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.